Drugs News and Research

RSS

A new study will research the best way to treat women with psychosis who then become pregnant

The national study will look at the best clinical practice for treating pregnant women with schizophrenia and other psychosis by setting up an Australian wide database of pregnant women with schizophrenia and related disorders. The study will follow the woman and her baby during pregnancy up to the first year of the baby's life.

29 Nov 2004

Guatemalan Congress repeals law that restricted access to medicines

The Guatemalan Congress's repeal of a law that severely restricts people's access to affordable essential medicines is a positive step forward.

29 Nov 2004

New class of drugs to repair psychiatric disorders

“Smart” drugs capable of targeting specific brain cells to control psychiatric disorders such as autism and schizophrenia may be ready for early clinical trials within three years, with the launch of a $1.5 million project to take place at the Brain Research Centre (BRC)

29 Nov 2004

Computer program helps decode cancer

Researchers at the University of Newcastle, Australia have developed a computer program that implements a novel algorithm, which will aid in the identification of specific cancer causing genes.

29 Nov 2004

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Manufacturers in the crowded and highly fragmented European active pharmaceutical ingredients (API) market are struggling to overcome a variety of challenges. One of the most pressing of these is the problem of overcapacity.

29 Nov 2004

Moldova making progress in fight against HIV/AIDS and tuberculosis

Moldova’s early actions to fight HIV/AIDS and tuberculosis are slowing the rise of the country’s dual tuberculosis and AIDS epidemics, the World Bank reports.

29 Nov 2004

Effective management of insomnia begins with recognition and adequate assessment

A seminar in this week’s issue of THE LANCET outlines the common but poorly understood condition of insomnia, concluding that awareness and assessment of insomnia by family doctors is a priority.

29 Nov 2004

Drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria

Results of a randomised trial from Uganda in this week’s issue of THE LANCET suggest that the drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria in terms of efficacy and cost-effectiveness in this region.

29 Nov 2004

Women with recurrent miscarriage and infertility are undergoing tests and treatments that have no scientific rationale

Women with recurrent miscarriage and infertility are undergoing tests and treatments that have no scientific rationale and are linked with known risks to mother and fetus, warn researchers in this week's BMJ.

29 Nov 2004

U.S. pharmacists not opposed to importing drugs to lower patients' costs

Many community pharmacists are not opposed to importing drugs to lower patients' costs as long as those drugs are channeled through U.S. pharmacies to ensure safety and efficacy, according to a study by pharmacists at the University of Illinois at Chicago and the University of Michigan.

24 Nov 2004

Shortages of health workers threaten health initiatives

A new study has for the first time quantified the dangerous scarcity of health care workers around the globe, ensuring future failures of most developing country health initiatives without the effective addition of 4 million health workers to stave off catastrophic health, economic and political consequences.

24 Nov 2004

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.

24 Nov 2004

Crystals may help to revolutionise drug discovery

A groundbreaking technique developed at The University of Manchester, which uses crystals to map ‘invisible’ parts of molecules, is set to revolutionise drug discovery.

From The University of Manchester 24 Nov 2004

Topical cream alternative to Vioxx

A clinical study recently published in The Journal of Rheumatology concludes that a topical cream consisting of a blend of natural oils called cetylated fatty acids significantly increased range of motion and physical performance in patients with osteoarthritis of the knee with no reported side effects.

24 Nov 2004

CDC admits obesity stats flawed - pharmaceutical and weight loss industry at fault

A Wall Street Journal bombshell report that the U.S. Centers for Disease Control and Prevention (CDC) has admitted to serious statistical errors in calculating that obesity kills 400,000 Americans each year is only the tip of the iceberg of gross exaggerations and miscalculations, according to The Center for Consumer Freedom (CCF).

24 Nov 2004

FDA incapable of protecting America against another Vioxx

The Food and Drug Administration (FDA) tried to discredit one of its own experts after he told a US Senate hearing that the FDA had failed to protect the public over rofecoxib (Vioxx), according to two articles published online by the British Medical Journal.

24 Nov 2004

Acid-resistant bug also alcohol-resistant

A chemist at Washington University in St. Louis has found surprisingly tough enzymes in a bacterium that "just says no to acid."

23 Nov 2004

Breakthrough HIV research wins prestigious industry award

Research that could lead to a breakthrough in the treatment of HIV has scooped a University of Manchester scientist a prestigious industry award.

From The University of Manchester 23 Nov 2004

Experimental compound prevents cholesterol gallstone disease

A promising experimental compound prevents cholesterol gallstone disease in mice by stimulating the biochemical pathway that controls bile acid secretion by the liver, according to new studies by Howard Hughes Medical Institute researchers.

23 Nov 2004

Stem cells' repair skills could be link to cancer

Johns Hopkins researchers say there is growing evidence that stem cells gone awry in their efforts to repair tissue damage could help explain why long-term irritation, such as from alcohol or heartburn, can create a breeding ground for certain cancers.

23 Nov 2004